Everolimus
Showing 1 - 25 of 1,175
Idiopathic Subglottic Tracheal Stenosis Trial in Baltimore (Everolimus Oral Tablet)
Recruiting
- Idiopathic Subglottic Tracheal Stenosis
- Everolimus Oral Tablet
-
Baltimore, MarylandJohns Hopkins Outpatient Center
Jul 28, 2022
Epilepsy Trial in Shenyang (Everolimus, Placebo)
Recruiting
- Epilepsy
- Everolimus
- Placebo
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Nov 5, 2022
Renal Angiomyolipoma Trial (Everolimus)
Not yet recruiting
- Renal Angiomyolipoma
- Everolimus
- (no location specified)
Aug 15, 2022
Coronary Artery Disease Trial in Fribourg (Implantation of everolimus-eluting bioresorbable vascular scaffold stent,
Completed
- Coronary Artery Disease
- Implantation of everolimus-eluting bioresorbable vascular scaffold stent
- +2 more
-
Fribourg, SwitzerlandFribourg Cantonal Hospital
Oct 14, 2021
Breast Cancer, Hormone Receptor Positive Tumor Trial in Germany (3 weeks Dose Induction of Everolimus, 3 weeks Conventional
Completed
- Breast Cancer
- Hormone Receptor Positive Tumor
- 3 weeks Dose Induction of Everolimus
- +3 more
-
Neu Isenburg, Hessen, Germany
- +13 more
Feb 22, 2022
Percutaneous Coronary Intervention (PCI), Coronary Artery Disease (CAD), De Novo Stenosis Trial in Tunis (DEB for de Novo
Recruiting
- Percutaneous Coronary Intervention (PCI)
- +2 more
- DEB for de Novo Lesions
- DES for de Novo Lesions
-
Tunis, TunisiaMilitary hospital of Tunis
Aug 23, 2022
Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)
Completed
- Bladder Cancer
- Metastatic Transitional Cell Carcinoma
- Everolimus
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 16, 2021
Breast Cancer Trial in United States (ARV-471 in combination with Everolimus)
Not yet recruiting
- Breast Cancer
- ARV-471 in combination with Everolimus
-
San Diego, California
- +4 more
Aug 12, 2022
Glioblastoma Multiforme, Glioma of Brain Trial in Chandler, Phoenix, Scottsdale (Ribociclib, Everolimus)
Active, not recruiting
- Glioblastoma Multiforme
- Glioma of Brain
- Ribociclib
- Everolimus
-
Chandler, Arizona
- +2 more
Mar 10, 2022
Breast Tumors, Endocrine Breast Diseases, Tumor Metastasis Trial in Baltimore (letrozole, lapatinib, everolimus)
Terminated
- Breast Neoplasms
- +2 more
- letrozole
- +2 more
-
Baltimore, MarylandUniversity of Maryland Marlene & Stewart Greenebaum Cancer Cente
Feb 9, 2022
Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)
Completed
- Solid Organ Malignancies
- +2 more
- Lenalidomide
- Everolimus
-
Atlanta, Georgia
- +1 more
Nov 19, 2021
Renal Cell Carcinoma Trial in Shanghai (Anlotinib HCl, everolimus)
Not yet recruiting
- Renal Cell Carcinoma
- Anlotinib hydrochloride
- everolimus
-
Shanghai, China270 Dongan Road, Fudan University Shanghai Cancer Center
Nov 5, 2021
Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)
Active, not recruiting
- Breast Cancer
- Letrozole
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 24, 2022
Uterine Sarcoma Trial (Everolimus)
Available
- Uterine Sarcoma
- Everolimus
- (no location specified)
Jun 30, 2021
Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)
Active, not recruiting
- Differentiated Thyroid Cancer
- Everolimus
- Sorafenib
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Oct 18, 2021
Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,
Terminated
- Low Grade Glioma
- +3 more
- Everolimus
- Temozolomide
-
San Francisco, CaliforniaUniversity of California, San Francisco
Nov 3, 2021
Neuroendocrine Tumors Trial in Boston, New York, Houston (LEE011, everolimus)
Active, not recruiting
- Neuroendocrine Tumors
- LEE011
- everolimus
-
Boston, Massachusetts
- +4 more
Feb 22, 2022
Stability of Tacrolimus, Cyclosporine A, Everolimus and
Recruiting
- Transplantation Drugs Stability
- Blood sampling
-
Turin, ItalyAOU Città della Salute e della Scienza di Torino/S.C Biochimica
Mar 10, 2022
Everolimus-containing Chemotherapy in HER2- mBC PI3K/AKT/mTOR
Completed
- Breast Cancer
- +2 more
- No intervention, it was a retrospective study.
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Sep 13, 2021
Pharmacokinetics Trial in Seoul (SVG101 (T), Afinitor (R))
Completed
- Pharmacokinetics
- SVG101 (T)
- Afinitor (R)
-
Seoul, Korea, Republic ofYonsei University Healthcare System, Severance Hospital
Aug 3, 2022
Ischemic Heart Disease Trial in Seoul (Implanatation of Genoss DES sirolimus-eluting coronary system, Implanatation of Xience
Recruiting
- Ischemic Heart Disease
- Implanatation of Genoss DES sirolimus-eluting coronary system
- Implanatation of Xience DES everolimus-eluting coronary system
-
Seoul, Korea, Republic ofCardiac and Vascular Center; Samsung Medical Center
Jun 29, 2022
Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)
Terminated
- Glioma
- +2 more
- Dasatinib
- Everolimus
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Oct 12, 2021
Progeria Trial in Boston (Everolimus and lonafarnib)
Enrolling by invitation
- Progeria
- Everolimus and lonafarnib
-
Boston, MassachusettsBoston Children's Hospital
Jun 11, 2021